Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe? - Wikidata - awgldk - TriplyDB

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

http://www.wikidata.org/entity/Q44353708

about

Review article: prescribing medications in patients with cirrhosis - a practical guide.Tuberculosis, lung infections, interstitial lung disease, social issues and journalology in AJRCCM 2003.Gene expression profiling reveals potential key pathways involved in pyrazinamide-mediated hepatotoxicity in Wistar rats.Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.Unexpected Hepatotoxicity of Rifampin and Saquinavir/Ritonavir in Healthy Male Volunteers.Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells.Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months.Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.

P2860

Q34342554-19CD2649-B7EF-449C-8129-94CD3200CA51 Q35626620-D3AE7A21-EAAB-4BFA-8460-374E8DAAEEF9 Q39638878-AD76E8D9-12A4-4600-8CCA-4C4D64A76820 Q40680333-DE15EE9A-47BD-4907-8D17-802F4958FC5D Q42618217-E2ED6E6C-42D0-4414-AB1F-7155BDFF8892 Q43080211-9CC9E5D2-8DCE-4AD3-8258-5A5C0AE18E1E Q44917828-08A455FE-CA68-4C6A-9000-9F7A7CC6850B Q45909196-ACB7772C-1356-4413-A065-0841736D8C95

P2860

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

http://www.wikidata.org/entity/Q44353708

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

@en

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

@nl

type

label

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

@en

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

@nl

prefLabel

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

@en

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

@nl

P1433

Q44353708-F66F2B40-89B6-43B2-8704-D73D55B57C75

P1476

Q44353708-E27CEC19-02EC-4078-BCD1-53F9A038594B

P2093

Q44353708-A63688D2-D051-4CB2-9065-1B2D90CC5461

Q44353708-F5B72F77-56BC-4797-9925-6C0B632BF8EA

P2860

Q44353708-2498A8C1-5240-46CC-92E2-8DEF4F83B3ED

Q44353708-2FF2CCBD-8FBA-4EF0-81EE-806FF3995C57

Q44353708-5EF6246B-E713-4A34-BFCD-971C945D4668

Q44353708-66DFB048-C140-4269-93ED-2CEF806CE39D

Q44353708-68F218C4-47F4-47FC-A3DE-9AAA6B4B2720

Q44353708-9310041B-CEB3-4081-BA6A-CDF00E1A3984

Q44353708-ABD4B602-3A26-4482-93E5-E53D8BA5AECF

Q44353708-C6198A27-F68B-4710-A49A-DCCFEA538EF9

Q44353708-D3DB9776-BCC4-43EE-9C04-AC39CDB2E187

P304

Q44353708-AF56B93D-81D3-46AB-B753-557479D1831F

P31

Q44353708-94953429-EB62-4682-82B6-001583742AD7

Q44353708-96183bcf-2b3d-4011-9525-640d444ae698

P356

Q44353708-20A052AE-54EF-4921-8D36-C7326EC402FC

P407

Q44353708-D259A4FB-15C0-4F53-99C3-DC3CBCAE6FC9

P433

Q44353708-0BD510EF-D5C5-4987-B3E5-C812F649F4D2

P478

Q44353708-7EBB222C-6929-44EA-9586-5E979D0E2316

P577

Q44353708-28BB708D-5C4D-4593-AF1C-5A79E27355B8

P5875

Q44353708-E11DF25D-236C-43F9-9B56-BFA5A0C68684

P698

Q44353708-E3DD8DAE-906C-482F-B045-AB8A7CE78F98

P921

Q44353708-89B0AD00-03AA-456F-995E-88B1DF966C46

P356

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?

@en

P2093

Charles L Daley

http://www.w3.org/2001/XMLSchema#string

Robert M Jasmer

http://www.w3.org/2001/XMLSchema#string

P2860

Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates.

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers.

Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis.

Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

P304

809-810

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.2301002

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10867499

http://www.w3.org/2001/XMLSchema#string

P698

12623855

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde